Alembic Company Profile
✉ Email this page to a colleague
What is the competitive landscape for ALEMBIC, and what generic and branded alternatives to ALEMBIC drugs are available?
ALEMBIC has one hundred and ninety approved drugs.
There are eight tentative approvals on ALEMBIC drugs.
Summary for Alembic
US Patents: | 0 |
Tradenames: | 148 |
Ingredients: | 147 |
NDAs: | 190 |
Patent Litigation for Alembic: | See patent lawsuits for Alembic |
PTAB Cases with Alembic as petitioner: | See PTAB cases with Alembic as petitioner |
Drugs and US Patents for Alembic
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Alembic | VALSARTAN AND HYDROCHLOROTHIAZIDE | hydrochlorothiazide; valsartan | TABLET;ORAL | 201662-002 | Mar 21, 2013 | AB | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ||||
Alembic | DAPSONE | dapsone | GEL;TOPICAL | 215718-001 | Oct 27, 2023 | AB | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ||||
Alembic Pharms Ltd | LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE | hydrochlorothiazide; losartan potassium | TABLET;ORAL | 091617-001 | Feb 17, 2012 | AB | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ||||
Alembic | DOXERCALCIFEROL | doxercalciferol | INJECTABLE;INJECTION | 215810-001 | Jun 15, 2023 | AP | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ||||
Alembic | PRAMIPEXOLE DIHYDROCHLORIDE | pramipexole dihydrochloride | TABLET;ORAL | 078894-004 | Oct 8, 2010 | DISCN | No | No | ⤷ Subscribe | ⤷ Subscribe | |||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.